Meropenem Steriscience (Meropenem Trihydrate)

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

• Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens, facilitating infection resolution.
• Complicated urinary tract infections: eradicates resistant Gram‑negative organisms, helping restore urinary tract sterility.
• Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant bacteria, improving respiratory function.
• Bacterial meningitis: penetrates the cerebrospinal fluid to eliminate causative pathogens, supporting neurological recovery.
• Sepsis: offers rapid bacterial killing in systemic infection, aiding hemodynamic stabilization.

• Meropenem binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This prevents cross‑linking of the cell wall, leading to osmotic instability and bacterial lysis. The molecule is stable against most β‑lactamases, including extended‑spectrum enzymes, extending its activity against a wide range of Gram‑positive and Gram‑negative organisms.

Adverse reactions to Meropenem Steriscience may vary in frequency and severity.

Common Side Effects

• Nausea: mild gastrointestinal discomfort.
• Diarrhea: loose stools that may lead to dehydration.
• Rash: mild skin erythema or itching.
• Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with respiratory compromise.
• Seizures: risk increased in patients with renal dysfunction.
• Clostridioides difficile colitis: severe intestinal infection.
• Neutropenia: significant drop in white blood cell count.

When using Meropenem Steriscience, consider the following precautions:

• Renal function: adjust dose in patients with impaired kidney function.
• Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy.
• Pregnancy: use only if benefits outweigh potential risks, as safety data are limited.
• Concomitant nephrotoxic drugs: monitor renal parameters when combined with aminoglycosides or vancomycin.
• Electrolyte monitoring: watch for hypokalemia during prolonged therapy.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid)

• Valproic acid: may reduce serum valproate levels, risking seizure breakthrough.
• High-dose aminoglycosides: increased risk of nephrotoxicity.
• Loop diuretics: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR, monitor coagulation.
• Probenecid: may increase meropenem plasma concentrations.
• Oral contraceptives: possible reduction in efficacy, advise additional contraception.